New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Enliven Therapeutics, Inc.
ELVN
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

1B

Biotechnology

Next Earning date - 14 Nov 2024

1B

Biotechnology

Next Earning date - 14 Nov 2024

29.48USD
Shape0.52 ( 1.78%)
Market Open
favorite-chart

Relative Strenght

89
favorite-chart

Volume Buzz

-90%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

2%

Quote Panel

Shape
Updated October 24, 2024
1W 1.67 % 1M 21.69 % 3M 17.85 % 1Y 141.68 %

Key Metrics

Shape
  • Market Cap

    1.39B


  • Shares Outstanding

    47.24M


  • Share in Float

    29.00M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    29.485


  • Average Volume

    241470


  • Beta

    0.931


  • Range

    9.8-30.03


  • Industry

    Biotechnology


  • Website

    https://www.enliventherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

3110.14x

P/S Ratio

4.57x

P/B Ratio

0.0

Debt/Equity

-18824.3%

Net Margin

$-1.9

EPS

How ELVN compares to sector?

P/E Ratio

Relative Strength

Shape

ELVN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$10K

ShapeNaN%

2025-Revenue

$2.51

Shape-512%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

H.C. Wainwright

initialise

Previous: Not converted

2024-09-09

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.72
vs -2.20

Q4.22

arrow
arrow

+158%

1.23
vs -2.12

Q1.23

arrow
arrow

N/A

-0.80
vs -2.24

Q2.23

arrow
arrow

N/A

-0.41
vs -1.76

Q3.23

arrow
arrow

N/A

-0.51
vs -0.72

Q4.23

arrow
arrow

N/A

-0.47
vs 1.23

Q1.24

arrow
arrow

N/A

-0.54
vs -0.80

Q2.24

arrow
arrow

N/A

-0.41
vs -0.41

Q3.24

arrow
arrow

N/A

-0.51
vs -0.51

Q4.24

arrow
arrow

N/A

-0.53
vs -0.47

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

440K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+15%

0.15
vs -0.14

Q4.22

arrow
arrow

+36%

0.36
vs 0.15

Q1.23

arrow
arrow

-4%

-0.04
vs 0.36

Q2.23

arrow
arrow

-6%

-0.06
vs -0.04

Q3.23

arrow
arrow

-8%

-0.08
vs -0.06

Q4.23

arrow
arrow

-8%

-0.08
vs -0.08

Q1.24

arrow
arrow

-7%

-0.07
vs -0.08

Q2.24

arrow
arrow

-7%

-0.07
vs -0.07

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News